IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas

Human Pathology

Volumn 40, Issue 10, 2009, Pages 1377-1383

  Riener, Marc Oliver ^a   Fritzsche, Florian R ^a   Clavien, Pierre Alain ^a   Pestalozzi, Bernhard C ^a   Probst Hensch, Nicole ^a   Jochum, Wolfram ^b   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Institute of Pathology   (Switzerland)

Author keywords

Bile duct carcinoma; Dysplasia; Immunohistochemistry; IMP3; KOC

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT INJURY; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DYSPLASIA; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

BILE DUCT NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 69949128563     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.024     Document Type: Article

References (29)

1. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
2. Wistuba I.I., and Gazdar A.F. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4 (2004) 695-706
3. Nielsen F.C., Nielsen J., and Christiansen J. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl 234 (2001) 93-99
4. Mueller-Pillasch F., Pohl B., Wilda M., et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 88 (1999) 95-99
5. Mueller-Pillasch F., Lacher U., Wallrapp C., et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 14 (1997) 2729-2733
6. Monk D., Bentley L., Beechey C., et al. Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome. J Med Genet 39 (2002) 575-581
7. Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M., and Nielsen F.C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19 (1999) 1262-1270
8. Yantiss R.K., Woda B.A., Fanger G.R., et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 29 (2005) 188-195
9. Jiang Z., Lohse C.M., Chu P.G., et al. Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer 112 (2008) 2676-2682
10. Jeng Y.M., Chang C.C., Hu F.C., et al. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 48 (2008) 1118-1127
11. Liao B., Hu Y., Herrick D.J., and Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 280 (2005) 18517-18524
12. Vikesaa J., Hansen T.V., Jonson L., et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 25 (2006) 1456-1468
13. Hamilton S., and Aaltonen L. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System (2000), IARC Press, Lyon
14. Riener M.O., Bawohl M., Clavien P.A., and Jochum W. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes Chromosomes Cancer (2008)
15. Ligato S., Zhao H., Mandich D., and Cartun R.W. KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies. Diagn Cytopathol 36 (2008) 561-567
16. Zheng W., Yi X., Fadare O., et al. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol 32 (2008) 304-315
17. Li C., Zota V., Woda B.A., et al. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Mod Pathol 20 (2007) 1263-1268
18. Li C., Rock K.L., Woda B.A., Jiang Z., Fraire A.E., and Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 20 (2007) 242-247
19. Li L., Xu H., Spaulding B.O., et al. Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol 39 (2008) 1205-1211
20. Pryor J.G., Bourne P.A., Yang Q., Spaulding B.O., Scott G.A., and Xu H. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol 21 (2008) 431-437
21. Simon R., Bourne P.A., Yang Q., et al. Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not. Hum Pathol 38 (2007) 1178-1183
22. Xu H., Bourne P.A., Spaulding B.O., and Wang H.L. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol 38 (2007) 555-563
23. Pryor J.G., Simon R.A., Bourne P.A., Spaulding B.O., Scott G.A., and Xu H. Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas. Hum Pathol 40 2 (2008) 238-243
24. Zhao H., Mandich D., Cartun R.W., and Ligato S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol 35 (2007) 700-704
25. Yantiss R.K., Cosar E., and Fischer A.H. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. Acta Cytol 52 (2008) 133-138
26. Lu D., Vohra P., Chu P.G., Woda B., Rock K.L., and Jiang Z. An Oncofetal Protein IMP3: A New Molecular Marker for the Detection of Esophageal Adenocarcinoma and High-grade Dysplasia. Am J Surg Pathol 33 4 (2009) 521-525
27. Hoffmann N.E., Sheinin Y., Lohse C.M., et al. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 112 (2008) 1471-1479
28. Sitnikova L., Mendese G., Liu Q., et al. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res 14 (2008) 1701-1706
29. Nemunaitis J., Meyers T., Senzer N., et al. Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer. Mol Ther 13 (2006) 1185-1191